Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04683471 · ClinicalTrials.gov registry record · NA
Pilot Trial of a System for Motor Function Recovery
A NA study of Spinal Cord Diseases, sponsored by Niche Biomedical, Inc. dba ANEUVO.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 3
- Study locations
NCT04683471: Completed NA study of Spinal Cord Diseases, sponsored by Niche Biomedical, Inc. dba ANEUVO.
NCT04683471 is a NA study of Spinal Cord Diseases that has completed, run by Niche Biomedical, Inc. dba ANEUVO. The registered enrollment target is 12 participants, below the 23-participant average among 9 other Spinal Cord Diseases trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04683471, a NA study of Spinal Cord Diseases, has completed, sponsored by Niche Biomedical, Inc. dba ANEUVO.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a multi-center, prospective, blinded, pilot feasibility study to evaluate improvement in sensory and motor function with sham.
Primary Outcome
Change in Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP) for the upper limbs Scoring: * Strength scored 0 - 50 for each arm * Sensibility scored 0 - 24 for each arm * Prehension scored 0 - 42 for each arm * Higher scores are a better outcome
Conditions Studied
Interventions
- DEVICE Sham
- DEVICE Stimulator
Study Locations (3)
Illinois
- Shirley Ryan AbilityLab - Chicago
Maryland
- Kennedy Krieger Institute - Baltimore
Texas
- Houston Methodist Research Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-11-30 |
| Est. Completion | 2022-03-22 |
| Phase | NA |
What the finished NCT04683471 record still lists
NCT04683471 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 23-participant average among 9 other Spinal Cord Diseases trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Spinal Cord Diseases appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.
NCT04683471 reports a single indexed study location in Illinois, Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT04683471 about?
NCT04683471 is a clinical study titled "Pilot Trial of a System for Motor Function Recovery". This is a multi-center, prospective, blinded, pilot feasibility study to evaluate improvement in sensory and motor function with sham.
What is the current status of trial NCT04683471?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-11-30. Estimated completion is 2022-03-22.
What conditions does trial NCT04683471 study?
This clinical trial studies the following conditions: Spinal Cord Diseases.
What interventions are being tested in trial NCT04683471?
The interventions under investigation include: Sham (DEVICE), Stimulator (DEVICE).
Who is sponsoring clinical trial NCT04683471?
This trial is sponsored by Niche Biomedical, Inc. dba ANEUVO, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04683471 being conducted?
This trial has 3 study locations across Illinois, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04683471's enrollment target sits among peer trials
12 6th of 9 higher than 2 of 9 other Spinal Cord Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
-
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
RECRUITING · NA
-
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
RECRUITING · NA
-
Multi-speed Ergonomic Wheelchair
RECRUITING · NA
-
Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI
ACTIVE NOT RECRUITING · NA
-
Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI